Recursion Pharmaceuticals had 5 insider transactions totaling $514,889.42. 4 were Tax Payments worth $436,067.04, and 1 was a Sale worth $78,822.38. Najat Khan accounted for 2 transactions totaling ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

A Brazil special: we hear from Sérgio Dávila, editor in chief of ‘Folha de São Paulo’ and Catarina Carvalho, executive director of ‘Piaui’ magazine. At the Arab Media Summit, we join AFP’s global news ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.